170 related articles for article (PubMed ID: 24055140)
1. CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.
Wang J; Chen X; Li P; Su L; Yu B; Cai Q; Li J; Yu Y; Liu B; Zhu Z
Chem Biol Interact; 2013 Nov; 206(2):230-8. PubMed ID: 24055140
[TBL] [Abstract][Full Text] [Related]
2. The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E.
Li W; Jin X; Deng X; Zhang G; Zhang B; Ma L
Biochem Biophys Res Commun; 2014 Jun; 449(2):235-40. PubMed ID: 24845562
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).
Shi X; Xiao X; Yuan N; Zhang S; Yuan F; Wang X
Oncol Res; 2018 Aug; 26(7):987-996. PubMed ID: 29295725
[TBL] [Abstract][Full Text] [Related]
4. ABCG2 confers promotion in gastric cancer through modulating downstream CRKL in vitro combining with biostatistics mining.
Wang J; Yunyun Z; Wang L; Chen X; Zhu Z
Oncotarget; 2017 Jan; 8(3):5256-5267. PubMed ID: 28029654
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
6. LAT-1 functions as a promotor in gastric cancer associated with clinicopathologic features.
Wang J; Chen X; Su L; Li P; Liu B; Zhu Z
Biomed Pharmacother; 2013 Oct; 67(8):693-9. PubMed ID: 23809372
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
He XP; Shao Y; Li XL; Xu W; Chen GS; Sun HH; Xu HC; Xu X; Tang D; Zheng XF; Xue YP; Huang GC; Sun WH
FEBS J; 2012 Nov; 279(22):4201-12. PubMed ID: 23013439
[TBL] [Abstract][Full Text] [Related]
8. miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
Guo C; Zhao D; Zhang Q; Liu S; Sun MZ
Sci Rep; 2018 Feb; 8(1):2375. PubMed ID: 29403024
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
Zheng B; Liang L; Huang S; Zha R; Liu L; Jia D; Tian Q; Wang Q; Wang C; Long Z; Zhou Y; Cao X; Du C; Shi Y; He X
Oncogene; 2012 Oct; 31(42):4509-16. PubMed ID: 22179828
[TBL] [Abstract][Full Text] [Related]
11. MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
Deng Y; Huang Z; Xu Y; Jin J; Zhuo W; Zhang C; Zhang X; Shen M; Yan X; Wang L; Wang X; Kang Y; Si J; Zhou T
Cancer Lett; 2014 Jan; 342(1):27-35. PubMed ID: 23981575
[TBL] [Abstract][Full Text] [Related]
12. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1.
Zhuang M; Gao W; Xu J; Wang P; Shu Y
Biochem Biophys Res Commun; 2014 Jun; 448(3):315-22. PubMed ID: 24388988
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.
Li X; Li H; Zhang R; Liu J; Liu J
Cell Physiol Biochem; 2015; 35(5):2033-42. PubMed ID: 25871967
[TBL] [Abstract][Full Text] [Related]
14. ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
Wang J; Zhou Y; Fei X; Chen X; Yan J; Liu B; Zhu Z
Oncol Rep; 2017 Apr; 37(4):2033-2040. PubMed ID: 28260063
[TBL] [Abstract][Full Text] [Related]
15. The role of CT10 regulation of kinase-like in cancer.
Guo C; Liu S; Sun MZ
Future Oncol; 2014 Dec; 10(16):2687-97. PubMed ID: 25531052
[TBL] [Abstract][Full Text] [Related]
16. MiR-126 inhibits the invasion of gastric cancer cell in part by targeting Crk.
Li X; Wang F; Qi Y
Eur Rev Med Pharmacol Sci; 2014; 18(14):2031-7. PubMed ID: 25027343
[TBL] [Abstract][Full Text] [Related]
17. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
18. miR-126 functions as a tumour suppressor in human gastric cancer.
Feng R; Chen X; Yu Y; Su L; Yu B; Li J; Cai Q; Yan M; Liu B; Zhu Z
Cancer Lett; 2010 Dec; 298(1):50-63. PubMed ID: 20619534
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer.
Zhang JK; Li YS; Zhang CD; Dai DQ
Cancer Cell Int; 2017; 17():28. PubMed ID: 28239297
[TBL] [Abstract][Full Text] [Related]
20. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
